|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-7-16
|
|
pubmed:abstractText |
One-year results of a randomized, double-blinded trial of Thymoglobulin versus Atgam for induction therapy in renal transplantation revealed that Thymoglobulin was associated with higher event-free survival (94% vs. 63%), less acute rejection (4% vs. 25%), and better graft survival. This article compares the safety and efficacy of Thymoglobulin versus Atgam induction through 5 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
136-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15257052-Adult,
pubmed-meshheading:15257052-Antilymphocyte Serum,
pubmed-meshheading:15257052-Double-Blind Method,
pubmed-meshheading:15257052-Female,
pubmed-meshheading:15257052-Follow-Up Studies,
pubmed-meshheading:15257052-Graft Rejection,
pubmed-meshheading:15257052-Graft Survival,
pubmed-meshheading:15257052-Humans,
pubmed-meshheading:15257052-Incidence,
pubmed-meshheading:15257052-Kidney Transplantation,
pubmed-meshheading:15257052-Male,
pubmed-meshheading:15257052-Middle Aged,
pubmed-meshheading:15257052-Neoplasms,
pubmed-meshheading:15257052-T-Lymphocytes,
pubmed-meshheading:15257052-Transplantation Conditioning,
pubmed-meshheading:15257052-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
|
|
pubmed:affiliation |
Department of Pharmacy, Washington University School of Medicine, St. Louis, MO, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
